Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | P.S.PHARMA | 1 | ₹58,530 |
| 2 | Schedule 2 | HINDUJA DISTRIBUTOR | 1 | ₹51,830 |
| 3 | Schedule 3 | P.S.PHARMA | 46 | ₹27,800 |
| 4 | Schedule 4 | P.S.PHARMA | 47 | ₹36,150 |
| 5 | Schedule 5 | P.S.PHARMA | 47 | ₹48,500 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
5 Oct 2024, 6:00 pmClosed
Budecort Respules
6903268
GEM/2024/B/5398188
Two Packet Bid
T Amoxycillin DT 250 Mg,T Amoxy Clav 625,T Amlodipin 5 mg,T Atenolol 50 Mg,T Atoravastatin 20 mg,T
15 days
Maharashtra; Nashik
Item wise evaluation
BOQ
9 documents required · 9 mandatory
3 yrs
₹3
50%
Exempted
5 Oct 2024
13 Sept 2024
5 Oct 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 1 | T Amoxycillin DT 250 Mg | 3,000 | Strips | Nashik | 15 | - |
| 2 | T Amoxy Clav 625 | 1,000 | Strips | Nashik | 15 | |
| 3 | T Amlodipin 5 mg | 20,000 | Strips | Nashik | 15 | - |
| 4 | T Atenolol 50 Mg | 15,000 | Strips | Nashik | 15 | |
| 5 | T Atoravastatin 20 mg | 10,000 | Strips | Nashik | 15 | |
| 6 | T B Complex | 15,000 | Strips | Nashik | 15 | |
| 7 | T Betahistidine 16 mg | 2,000 | Strips | Nashik | 15 | |
| 8 | T Calcium 500 | 17,000 | Strips | Nashik | 15 | |
| 9 | T Cefixim 200 mg | 8,000 | Strips | Nashik | 15 | |
| 10 | T CPM 4 | 20,000 | Strips | Nashik | 15 | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6903268.pdf
GEM_BID
tablet_specification_2024-09-13-16-44-42_d1e1d612a6f44e952f7cb45c06d103a6.pdf
BOQ
tablet_2024-09-13-16-44-43_c67e9b126b7528579da54920f170ac58.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .